INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Filing Date
Global Rank
#2,864
/ 6,895
▼ 102
Top Industry
Biotechnology
66.0%
3Y Alpha vs SPY
-5.2%
Period ended 2 years ago
Filed Nov 14, 2023 · 2y
15 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+54.5%
SPY
+76.3%
Annualised alpha
-5.2%
Max drawdown
−27.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
55 positions · as of Sep 30, 2023 · Δ vs Jun 30, 2023Top Position
8.4%
−0.8 pts
Top 5
33.5%
−3.3 pts
Top 10
52.5%
−7.5 pts
HHI
393
Diversified−60
Portfolio Trend
15 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2023| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $253,568,997 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
15 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| QURE | uniQure N.V. | +1,226,000 | 1,241,500 | $8,330,465 | |
| ERAS | Erasca, Inc. | +500,000 | 1,926,000 | $3,794,220 | |
| AUPH | Aurinia Pharmaceuticals Inc. | +467,000 | 1,040,530 | $8,084,918 | |
| IOVA | Iovance Biotherapeutics, Inc. | +380,000 | 445,000 | $2,024,750 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | +270,000 | 295,000 | $5,401,450 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +170,000 | 250,052 | $8,914,353 | |
| BMRN | Biomarin Pharmaceutical Inc | +95,000 | 153,656 | $13,595,482 | |
| GILD | Gilead Sciences, Inc. | +89,000 | 233,584 | $17,504,784 | |
| XENE | Xenon Pharmaceuticals Inc. | +66,000 | 91,500 | $3,125,640 | |
| NVCR | NovoCure Ltd | +42,000 | 74,000 | $1,195,100 | |
| BIIB | Biogen Inc. | +29,200 | 40,200 | $10,331,802 | |
| ACAD | Acadia Pharmaceuticals Inc | +28,702 | 179,702 | $3,744,989 | |
| SRPT | Sarepta Therapeutics, Inc. | +7,900 | 26,700 | $3,236,574 | |
| ONC | BeOne Medicines Ltd. | +4,000 | 12,700 | $2,284,349 | |
| KRYS | Krystal Biotech, Inc. | +147 | 46,092 | $5,346,672 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
11 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| HRMY | Harmony Biosciences Holdings, Inc. | −256,000 | 314,500 | $10,306,165 | |
| VERA | Vera Therapeutics, Inc. | −216,872 | 758,355 | $10,397,047 | |
| DYN | Dyne Therapeutics, Inc. | −163,000 | 137,751 | $1,234,248 | |
| SUPN | Supernus Pharmaceuticals, Inc. | −97,000 | 426,500 | $11,758,605 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | −44,800 | 36,800 | $6,517,280 | |
| NBIX | Neurocrine Biosciences Inc | −40,000 | 28,877 | $3,248,662 | |
| AMGN | Amgen Inc | −38,000 | 79,246 | $21,298,154 | |
| DNLI | Denali Therapeutics Inc. | −34,000 | 154,000 | $3,177,020 | |
| HALO | Halozyme Therapeutics, Inc. | −33,300 | 62,200 | $2,376,040 | |
| UTHR | UNITED THERAPEUTICS Corp | −18,800 | 33,959 | $7,670,319 | |
| REGN | Regeneron Pharmaceuticals, Inc. | −18,153 | 8,847 | $7,280,727 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 63,000 | $2,859,570 | |
| GMAB | Genmab A/S | 44,300 | $1,562,461 | |
| COGT | Cogent Biosciences, Inc. | 135,000 | $1,316,250 | |
| FOLD | AMICUS THERAPEUTICS, INC. | 90,000 | $1,094,400 | |
| PRTA | Prothena Corp Public Ltd Co | 15,000 | $723,750 | |
| VIR | Vir Biotechnology, Inc. | 47,000 | $440,390 | |
| No positions match the current search. | ||||
55 positions ·
$253,568,997 total
· as of Sep 30, 2023
Showing 1–50
of 55 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| AMGN |
Amgen Inc
Healthcare
|
Reduced | 79,246 | $21,298,154 | 8.40% | |
| INCY |
Incyte Corp
Healthcare
|
Held | 358,454 | $20,707,887 | 8.17% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
Added | 233,584 | $17,504,784 | 6.90% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 153,656 | $13,595,482 | 5.36% | |
| SUPN |
Supernus Pharmaceuticals, Inc.
Healthcare
|
Reduced | 426,500 | $11,758,605 | 4.64% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 758,355 | $10,397,047 | 4.10% | |
| BIIB |
Biogen Inc.
Healthcare
|
Added | 40,200 | $10,331,802 | 4.07% | |
| HRMY |
Harmony Biosciences Holdings, Inc.
Healthcare
|
Reduced | 314,500 | $10,306,165 | 4.06% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 250,052 | $8,914,353 | 3.52% | |
| QURE |
uniQure N.V.
Healthcare
|
Added | 1,241,500 | $8,330,465 | 3.29% | |
| AUPH |
Aurinia Pharmaceuticals Inc.
Healthcare
|
Added | 1,040,530 | $8,084,918 | 3.19% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Reduced | 33,959 | $7,670,319 | 3.02% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Held | 21,000 | $7,302,540 | 2.88% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Reduced | 8,847 | $7,280,727 | 2.87% | |
| ILMN |
Illumina, Inc.
Healthcare
|
Held | 50,500 | $6,743,815 | 2.66% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Reduced | 36,800 | $6,517,280 | 2.57% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Added | 295,000 | $5,401,450 | 2.13% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Added | 46,092 | $5,346,672 | 2.11% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Held | 58,300 | $4,074,587 | 1.61% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Added | 1,926,000 | $3,794,220 | 1.50% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Added | 179,702 | $3,744,989 | 1.48% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 28,877 | $3,248,662 | 1.28% | |
| SRPT |
Sarepta Therapeutics, Inc.
Healthcare
|
Added | 26,700 | $3,236,574 | 1.28% | |
| RCKT |
Rocket Pharmaceuticals, Inc.
Healthcare
|
Held | 156,000 | $3,196,440 | 1.26% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
Reduced | 154,000 | $3,177,020 | 1.25% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Added | 91,500 | $3,125,640 | 1.23% | |
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
NEW | 63,000 | $2,859,570 | 1.13% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Held | 18,300 | $2,672,532 | 1.05% | |
| LEGN |
Legend Biotech Corp
Healthcare
|
Held | 38,000 | $2,552,460 | 1.01% | |
| HALO |
Halozyme Therapeutics, Inc.
Healthcare
|
Reduced | 62,200 | $2,376,040 | 0.94% | |
| ONC |
BeOne Medicines Ltd.
Healthcare
|
Added | 12,700 | $2,284,349 | 0.90% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
Held | 17,200 | $2,226,368 | 0.88% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Held | 67,500 | $2,133,000 | 0.84% | |
| IOVA |
Iovance Biotherapeutics, Inc.
Healthcare
|
Added | 445,000 | $2,024,750 | 0.80% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Held | 43,000 | $1,950,480 | 0.77% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
Held | 78,958 | $1,919,468 | 0.76% | |
| GMAB |
Genmab A/S
Healthcare
|
NEW | 44,300 | $1,562,461 | 0.62% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Held | 48,099 | $1,323,684 | 0.52% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
NEW | 135,000 | $1,316,250 | 0.52% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Reduced | 137,751 | $1,234,248 | 0.49% | |
| NVCR |
NovoCure Ltd
Healthcare
|
Added | 74,000 | $1,195,100 | 0.47% | |
| FOLD |
AMICUS THERAPEUTICS, INC.
Healthcare
|
NEW | 90,000 | $1,094,400 | 0.43% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Held | 37,000 | $1,090,020 | 0.43% | |
| GH |
Guardant Health, Inc.
Healthcare
|
Held | 36,500 | $1,081,860 | 0.43% | |
| INSM |
INSMED Inc
Healthcare
|
Held | 40,100 | $1,012,525 | 0.40% | |
| NTLA |
Intellia Therapeutics, Inc.
Healthcare
|
Held | 24,000 | $758,880 | 0.30% | |
| PRTA |
Prothena Corp Public Ltd Co
Healthcare
|
NEW | 15,000 | $723,750 | 0.29% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Held | 24,000 | $594,000 | 0.23% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
Held | 23,500 | $565,175 | 0.22% | |
| VIR |
Vir Biotechnology, Inc.
Healthcare
|
NEW | 47,000 | $440,390 | 0.17% |